Cervical cancer
The exceedingly low uptake of high-risk human papillomavirus (HPV) vaccine constitutes a critical gap in Pakistan's public health strategy. Cervical cancer, primarily caused by HPV infections, is one of the most preventable yet deadly cancers affecting women globally. According to the International Agency for Research on Cancer (IARC), cervical cancer is the fourth most common cancer among women, with 604,000 new cases and 342,000 deaths reported worldwide in 2020.
In contrast, many Western nations have made impressive strides in combating this disease. Data from Australia's National HPV Vaccination Programme show that robust vaccination efforts have led to a reduction of over 70% in HPV infections among vaccinated cohorts. These countries have embraced the WHO guidelines, which recommend routine HPV vaccination for girls aged 9 to 14 years. Specifically, the WHO advises a two-dose schedule for those vaccinated before their 15th birthday and a three-dose schedule for older recipients. Furthermore, the vaccine is over 90% effective in preventing infections with HPV types 16 and 18 — the strains responsible for nearly 70% of cervical cancer cases.
Regrettably, Pakistan lags significantly behind, with HPV vaccination coverage estimated to be below 5%. Local estimates further suggest an age-standardised incidence rate for cervical cancer ranging between 6.0 and 10.0 per 100,000 women, although these figures are likely underreported due to limited screening programmes.
Policymakers, health authorities and community leaders must integrate HPV vaccination into our national immunisation programme. Through improved vaccine coverage and comprehensive public education, we can significantly reduce the future burden of cervical cancer and safeguard the health of our women.
Saba Ali Nawaz
Islamabad
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Recorder
12 hours ago
- Business Recorder
WHO's stepped up higher tax drive may fuel illicit cigarette trade
LAHORE: As the World Health Organisation (WHO) intensified its global drive for greater tobacco taxes, there are growing concerns in Pakistan that the strategy may have the opposite impact. While intended to reduce smoking, the WHO's tax-centric approach is exacerbating an already rampant illicit cigarette trade, harming legitimate businesses, depleting public cash, and undermining regulatory integrity, experts of the industry said. Pakistan has become a case study of unforeseen effects. Despite heavy taxation in accordance with WHO recommendations, the market has seen a noticeable shift toward illicit cigarette consumption, they said. It may be added that legal tobacco companies now control less than half of the market, although accounting for roughly 98% of the industry's tax revenue. Untaxed and unregulated brands have invaded retail shelves across the country, often selling for less than the legal minimum price and without tax stamps. 'The illicit cigarette trade has now overtaken the legitimate sector, comprising 58% of the total market. Pakistan's annual consumption is around 82 billion sticks, yet only 34 billion are taxed, down sharply from 67 billion a decade ago,' said Asad Shah, Director at Pakistan Tobacco Company (PTC). Shah noted that tax revenue potential from the sector stands at around PKR 570 billion annually, but actual collection reached just PKR 292 billion in FY 2023–24 and only PKR 223 billion in the first 11 months of the current fiscal year. Although the WHO acknowledges illicit trade as a challenge, its policy guidance continues to emphasize taxation over enforcement. 'It's burdening compliant manufacturers while failing to curtail illicit and smuggled brands,' Shah added. Experts said that public health objectives must be pursued alongside strong enforcement mechanisms, not only tax increases. Without this balance, the policy risks facilitating tax evasion, undermining investor confidence, and eroding public trust in the regulatory system. Copyright Business Recorder, 2025
Business Recorder
3 days ago
- Business Recorder
Counterfeit medicines: PM launches drive to eradicate black market
ISLAMABAD: Prime Minister Shehbaz Sharif on Thursday launched a bold drive to eradicate the lucrative and deadly black market for counterfeit medicines in the country, calling for urgent adoption of cutting-edge technology to tackle the growing menace. Chairing a high-level meeting focusing on the Ministry of National Health, Sharif made it clear there will be no tolerance for substandard drugs putting lives at risk. He urged pharmaceutical companies to seek accreditation from the World Health Organization (WHO). He said such recognition would raise the quality standards of Pakistani medicines and expand export opportunities. Sharif also directed officials to develop a roadmap for collaboration between welfare organisations and the private sector to improve medical services in Islamabad. He described providing top-quality healthcare to the public as a government priority. The prime minister stressed the importance of third-party validation for medical colleges to ensure high standards of education, warning that no compromises would be tolerated. He reiterated that political interference in health sector reforms would not be accepted. The Health Ministry officials briefed the prime minister on challenges facing the health sector and proposed sustainable solutions. They revealed plans to fully digitalise the registration process for medicines and medical equipment by the end of next month. Additionally, efforts are underway to integrate newly established basic health units, regional blood centres, and the Isolation Hospital and Infection Treatment Centre in Islamabad into the mainstream healthcare system with support from the country's affluent class. In a separate meeting, Sharif reviewed progress on the Jinnah Medical Complex and Research Center project in Islamabad, stressing the need for transparency throughout all stages. He described the complex as a future state-of-the-art hospital that will provide advanced medical services and research facilities to the region. The meeting was told that promotional roadshows had been held in China, Turkey, South Korea, and Singapore, attracting interest from globally renowned companies. Two major conferences related to the project also saw participation from 33 companies across 10 countries. The process to acquire 600 acres of land for the complex is reportedly progressing rapidly, with international advertisements placed to recruit experts and consultants. Copyright Business Recorder, 2025
Business Recorder
4 days ago
- Business Recorder
Israel says WHO ‘selective silence' deafening after hospital hit in Iranian strike
GENEVA: Israel accused the World Health Organization of a deafening 'selective silence' after a hospital in southern Israel was hit in an Iranian missile strike on Thursday. Daniel Meron, Israel's ambassador to the United Nations in Geneva, said the Soroka Hospital in Beersheba was a civilian facility. In a video on X filmed outside the WHO's headquarters, he demanded a condemnation from the UN health agency. A few hours later, WHO chief Tedros Adhanom Ghebreyesus issued a statement saying the reports on attacks on health in the conflict between Iran and Israel were 'appalling', citing the hospital. The Soroka Hospital was left in flames by a bombardment that Iran said targeted a military and intelligence base. In his video, Meron was standing at the road entrance to the WHO's offices in Geneva, with the main building visible in the background. 'I'm here with a clear message to the WHO, to the director general of the WHO, Dr Tedros,' Meron said. Trump to decide on US action in Israel-Iran conflict within two weeks, White House says 'A few hours ago, a ballistic missile was shot from Iran directly at the main hospital in the south of Israel, the Soroka Hospital. Dozens of people were wounded and hundreds were evacuated from this hospital. 'It is not a military site. It is a civilian hospital… the selective silence of the WHO is deafening. 'They must condemn the shooting of ballistic missiles and the targeting from Iran at civilian targets in Israel.' The WHO has repeatedly mentioned damage to healthcare infrastructure in the Gaza Strip since the start of the war in the Palestinian territory, triggered by the October 7, 2023 attacks by Hamas. On Tuesday, the WHO said only 17 of Gaza's 36 hospitals were currently minimally to partially functional. In a message later Thursday on X, Tedros said: 'The escalation of hostilities between Israel and Iran is putting health facilities and access to health care at risk. The reports on the attacks on health so far are appalling.' He cited 'this morning's attack on Soroka Medical Centre', and a hospital in Kermanshah in Iran being 'impacted by a nearby explosion'. 'We call on all parties to protect health facilities, health personnel and patients at all times,' said Tedros. WHO's director for Europe Hans Kluge said he was 'deeply disturbed to learn of the attack on Soroka Hospital', having visited it following the October 7, 2023 attacks. 'Hospitals and health workers must never be targets – under any circumstances,' Kluge said. Israel is in the WHO's Europe region.
